6CM
TFFP

683 Capital Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

683 Capital Management’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,681
Closed -$2.03M – 243
2020
Q4 		$2.03M Buy
5,681
+975
+21% +$375K 0.1% 99
2020
Q3 		$2.17M Buy
+4,706
New +$1.33M 0.16% 79

Other funds holding TFFP

CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

683 Capital Management's TFFP Position: Q1 2021 in Review

683 Capital Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q1 2021, closing a stake of 5,681 shares — an estimated $2.03M sold.

683 Capital Management first reported a position in TFFP in Q3 2020 and held it in 2 quarters. The position peaked at $2.17M in Q3 2020. 63 funds tracked by Wall St. Rank hold TFFP as of Q1 2021.

  • 683 Capital Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • 683 Capital Management sold 5,681 TFF Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $2.03M.
  • 683 Capital Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • 683 Capital Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $2.17M in Q3 2020.
  • 63 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on 683 Capital Management's 13F filing for Q1 2021, filed 17 May 2021.